U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07334301) titled 'A Multi-Arm, Platform Trial For Relapsed Neuroblastoma' on Sept. 12, 2025.
Brief Summary: Neuroblastoma is one of the most common solid childhood tumours, and a major cause of cancer-related death in children. More than 1200 children/young adults a year are diagnosed in USA and Europe. Around 600 of these cases are considered high-risk, which means the cancer is more difficult to treat successfully. Despite improvements in survival over recent decades, a significant proportion of patients with high-risk neuroblastoma have disease that does not respond to standard treatments (refractory neuroblastoma) or comes back after completion o...